Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Drug Company PI Date Risk List Available? Sort descending
Bleomycin Amneal Biosciences July 2016
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Trimethoprim/Sulfamethoxazole (Septra) Pfizer August 2018
Fluconazole (Diflucan) Pfizer March 2018
Rifabutin Greenstone LLC April 2018
VinCRIStine Sulfate Hospira, Inc. July 2013
Ledipasvir/Sofosbuvir (Harvoni) Gilead November 2017
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences April 2017
Ribavirin - New Aurobindo Pharma Limited October 2018
Isoniazid Sandoz Inc. October 2018
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Pitavastatin (Livalo)         Kowa November 2016
Rifabutin (Mycobutin) Pfizer April 2018
Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate (Teevir) Mylan Pharmaceuticals September 2014
Rifampin Lannett Company Inc. March 2019
Tamoxifen Citrate Mylan Pharmaceuticals April 2013
Ritonavir (Norvir) Tablets/Oral Solution AbbVie November 2018
Vorinostat (Zolinza) Merck December 2018
Bleomycin Hospira, Inc June 2018
Bedaquiline (Sirturo) Janssen October 2018


No records to display.